Postoperative complications in a case of iatrogenic hypothyroidism induced by diet drugs;Complicaciones postoperatorias de un hipotiroidismo iatrogeno no detectado inducido por farmacos adelgazantes

Revista Espanola de Anestesiologia y Reanimacion

Volumn 45, Issue 8, 1998, Pages 349-352

  Fernandez Torres B ^a,b   Gutierrez Garcia J ^a   Marquez Espinos C ^a   Gomez Sanchez S ^a  

^a HOSPITAL PUNTA DE EUROPA   (Spain)

^b NONE   (Spain)

Author keywords

Hypothyroidism, complications; Iatrogenic hypothyroidism; Postoperative hypothyroidism; Thyroid extracts

Indexed keywords

ANOREXIGENIC AGENT; THYROID EXTRACT; THYROXINE;

ADULT; ARTICLE; CASE REPORT; DRUG WITHDRAWAL; FEMALE; HEMODYNAMICS; HUMAN; HYPOTHYROIDISM; INTENSIVE CARE; MYXEDEMA; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRESCRIPTION; THYROID FUNCTION; WEIGHT REDUCTION;

APPETITE DEPRESSANTS; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; HYPOTHYROIDISM; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; THYROXINE; TRIIODOTHYRONINE;

EID: 0031736970     PISSN: 00349356     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Dyer RG. Traditional treatment of obesity: does it work? Baillieres Clin Endocrinol Metab 1994; 8: 661-688.
2. Stunkard AJ. Current views on obesity. Am J Med 1996; 100: 230-236.
3. Elks ML. Appetite suppressants as adjuncts in the treatment of obesity. J Fam Pract 1996; 42: 287-292.
4. Carek PJ, Sherer JT, Carson DS. Management of obesity: medical treatment options. Am Fam Physician 1997; 55: 551-558, 561-562.
5. Atkinson RL, Blank RC, Loper JF, Schumacher D, Lutes RA. Combined drug treatment of obesity. Obes Res 1995; 3 (Supl 4): 497-500.
6. Sawin CT, London MH. "Natural", desiccated thyroid. A "healthfood" thyroid preparation. Arch Intern Med 1989; 149: 2.117-2.118.
7. Lev Ran A. Part-of-the-day hypertrilodothyroninemia caused by desiccated thyroid. JAMA 1983; 250: 2.790-2.791.
8. Murkin JM. Anesthesia and hypothyroidism: a review of thyroxine physiology, farmacology and anesthetic implications. Anesth Analg 1982; 61: 371-383.
9. Scarpinatio L, Vacek JL. Myocardial infarction: severe reversible ischemia and shock following excess thyroid administration in a man with normal coronary arteries. Arch Intern Med 1989; 149: 701.
10. Bhasin S, Wallace W, Laurence JB, Lesch M. Sudden death associated with thyroid hormone abuse. Am J Med 1981; 71: 887-890.
11. Wartofsky L. Enfermedades del tiroides. En: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, editores. Harrison: principios de medicina interna, Madrid: McGraw-Hill-Interamericana de España, 1994; 2.226-2.251.
12. Foz M, Sanmartí A, Lucas A. Enfermedades del tiroides. En: Farreras P, Rozman C, Castillo R, Estapé J, Foz M, Lience E et al, editores. Medicina interna. Madrid: Mosby-Doyma Libros, 1995; 2.053-2.097.
13. Heim JH. Hypothyroidie d'origine centrale reversible a l'arret d'un traitement par Triac. Ann Med Intern París 1982; 133: 588-589.
14. Bentin J, Desir D, Mockel J. Triac (3,5,3′-triiodo-thyroacetic acid) induced "pseudohypothyroidism". Acta Clin Belg 1984; 39: 285-289.
15. Roizen MF. Implicaciones anestésicas de las enfermedades concurrentes. En: Miller RD, Cucciara RF, Miller ED, Reves JG, Roizen MF, Savarese JJ, editores. Anestesia. Barcelona: Doyma, 1993; 721-812.
16. Singh BN, Nademanee K. Amiodarone and thyroid function: clinical implications during antiarrhythmic therapy. Am Heart J 1983; 106: 857-869.
17. Mazonson PD, Williams ML, Cantley LK, Dalldorf FG, Utiger RD, Foster JR. Myxedema coma during long-term amiodarone therapy. Am J Med 1984; 77: 751-754.
18. Kaplan J, Ish-Shalom S. Goiter and hypothyroidism during re-treatment with amiodarone in a patient who previously experienced amiodarone-induced thyrotoxicosis. Am J Med 1991; 90: 750-752.
19. Roti E, Minelli R, Gardini E, Bianconi L, Braverman LE. Thyrotoxicosis followed by hypothyroidism in patients treated with amiodarone. A possible consequence of a destructive process in the thyroid. Arch Intern Med 1993; 153: 886-892.
20. Caron P. Effects de l'amiodarone sur la fonction thyroidienne. Presse Med 1995; 24: 1.747-1.751.
21. Di Leo A, Bajetta E, Ferrari L, Biganzoli L, Marini L, Carnaghi CTI et al. A dose-finding study of lanreotide (a somatostatin analog) in patients with colorectal carcinoma. Carncer 1996; 78: 35-42.
22. Jorgensen JO, Moller J, Skakkebaek NE, Weeke J, Christiansen JS. Thyroid function during growth hormone therapy. Horm Res 1992; 38: 63-67.
23. McConnell RJ. Abnormal thyroid function tests results in patients taking salsalate. JAMA 1992; 267: 1.242-1.243.
24. Becker CG, Gordon JM. Iodinated glycerol and thyroid dysfunction. Four cases and a review of the literature. Chest 1993; 103: 188-192.
25. Figg WD, Thibault A, Sartor AO, Mays D, Headlee D, Calis KA et al. Hypothyroidism associated with aminoglutethimide in patients with prostate cancer. Arch Intern Med 1994; 154: 1.023-1.025.
26. Mattijssen VJ, De Mulder PH, Van Liessum PA, Corstens FH, Franks CR, Wagener DJ. Hypothyroidism and goiter in a patient during treatment with interleukin-2. Cancer 1990; 65: 2.686-2.688.
27. Van Liessum PA, De Mulder PH, Mattijssen EJ, Corstens FH, Wagener DJ. Hypothyroidism and goitre during interleukin-2 therapy without LAK cells. Lancet 1989; 1: 224.
28. Atkins MB, Mier JW, Parkinson DR, Gould JA, Berkman EM, Kaplan MM. Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells. N Engl J Med 1988; 318: 1.557-1.563.
29. Hoekman K, Von Blomberg-Van der Flier BM, Wagstaff J, Drexhage HA, Pinedo HM. Reversible thyroid dysfunction during treatment with GM-CSF. Lancet 1991; 338: 541-542.
30. Kallner G, Petterson U. Renal, thyroid and parathyroid function during lithium treatment: laboratory tests in 207 people treated for 1-30 years. Acta Psychiatr Scand 1995; 91: 48-51.
31. Gupta A, Eggo MC, Uetrecht JP, Cribb AE, Daneman D, Rieder MJ et al. Drug-induced hypothyroidism: the thyroid as a target organ in hypersensitivity reactions to anticonvulsants and sulfonarmides. Clin Pharmacol Ther 1992; 51: 56-57.
32. Drucker D, Eggo MC, Salit IE, Burrow GH Ethionamide-induced goitrous hypothyroidism. Ann Intern Med 1984; 100: 837-839.
33. Marcellin P, Pouteau M, Renard P, Grynblat JM, Colas-Linhart N, Bardet P. Sustained hypothyroidism induced by recombinant alpha interferon in patients with chronic hepatitis C. Gut 1992; 33: 855-856.
34. Carella C, Amato G, Biondi B, Rotondi M, Morisco F, Tuccillo C et al. Longitudinal study of antibodies against thyroid in patients undergoing interferon-alpha therapy for HCV chronic hepatitis. Horm Res 1995; 44: 110-114.
35. Arena J, Eguileor I, Emparanza J. Repercusion sobre la función tiroidea del RN a término de la aplicación de povidona iodada en el muñón umbilical. An Esp Pediatr 1985; 23: 562-568.
36. Schlieriger JL. Accroissement des besoins en thyroxine par le sulfate de fer. Presse Med 1994; 23: 492.
37. Kitching NH. Hypothyroidism after treatment with ketoconazole. Br Med J Clin Res Ed 1986; 18; 293: 993-994.